Home/Filings/4/0001104659-23-062798
4//SEC Filing

Deflin Gayle 4

Accession 0001104659-23-062798

CIK 0001297184other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 6:30 PM ET

Size

4.9 KB

Accession

0001104659-23-062798

Insider Transaction Report

Form 4
Period: 2023-05-18
Deflin Gayle
Director
Transactions
  • Sale

    Common Stock

    2023-05-18$44.01/sh4,519$198,8884,163 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001866024

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:30 PM ET
Size
4.9 KB